tirzepatide τιμη GLP-1/GIP Rx Compounded Tirzepatide (GLP-1/GIP) Injections |

Most side effects occur during dose changes, particularly gastrointestinal issues that usually lessen over time (Kushner et al., 2025)

Tirzepatide Injection: Administration and Usage The most frequent search query users find themselves needing when using this drug is tirzepatide injection . Tirzepatide injection is given as a subcutaneous injection under the skin

During the 20232024 shortage, large-scale compounding was permitted

From there, your provider may increase the dose in 2.5 mg increments every four weeks until reaching a maintenance dose between 5 mg and 15 mg weekly

What the label actually says The Mounjaro and Zepbound prescribing information states: "Available data with tirzepatide use in pregnant women are insufficient to evaluate for a drug-related risk of major birth defects, miscarriage, or other adverse maternal or fetal outcomes." The label then references animal studies: "Based on animal reproduction studies, there may be risks to the fetus from exposure to tirzepatide during pregnancy." And the recommendation: "Advise pregnant women of the potential risk to a fetus

Its the real deal